OSUR

OraSure Technologies (OSUR)

About OraSure Technologies (OSUR)

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.

Details

Daily high
$4.09
Daily low
$4.00
Price at open
$4.02
52 Week High
$8.45
52 Week Low
$3.92
Market cap
300.5M
Dividend yield
0.00%
Volume
497,322
Avg. volume
537,690
P/E ratio
11.17

OraSure Technologies News

Details

Daily high
$4.09
Daily low
$4.00
Price at open
$4.02
52 Week High
$8.45
52 Week Low
$3.92
Market cap
300.5M
Dividend yield
0.00%
Volume
497,322
Avg. volume
537,690
P/E ratio
11.17